Voya Financial reports 6.3% stake in Tandem Diabetes Care
Voya Financial, Inc. reports beneficial ownership of Tandem Diabetes Care common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Voya Financial, Inc. reports beneficial ownership of Tandem Diabetes Care common stock. Voya states it beneficially owns 4,343,683 shares, representing 6.3% of the class, with 2,325,854 shares of sole voting power and sole dispositive power over all 4,343,683 shares. The report is filed by the ultimate parent on behalf of wholly owned subsidiaries and is signed by Voya's SVP, Chief Compliance and Deputy General Counsel.
Insights
Large passive holding disclosed: Voya holds 6.3% of Tandem Diabetes Care.
Voya Financial, as ultimate parent, reports beneficial ownership of 4,343,683 shares and sole dispositive power over that position. The filing follows Schedule 13G presentation norms for passive or investment-manager holdings and lists subsidiaries on Exhibit A.
Ownership size at 6.3% can be relevant for monitoring voting outcomes and potential reporting triggers; further detail on trading intent or investment mandate is not provided in the excerpt.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficial ownership financial
Sole dispositive power regulatory
Ultimate parent other
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Voya Financial report in Tandem Diabetes Care (TNDM)?
Who filed the Schedule 13G for TNDM on behalf of Voya Financial?
What percent ownership requires Schedule 13G disclosure?
AI-generated analysis. How Rhea-AI works. Not financial advice.